Investigational Site Number 4100008

Seoul 05505

0 studies enrolling now · 2 studies all time

What they study most

Chronic Kidney Diseases, Heart Failure, Type 2 Diabetes Mellitus

Studies at this site

• Effect of Sotagliflozin on Cardiovascular and Renal Events in Participants With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk — Stopped early
• Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Alone or in Combination With Oral Antidiabetic Drug(s) — Stopped early